http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105462975-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
filingDate | 2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105462975-B |
titleOfInvention | One species specificity suppresses siRNA and its application of CTGF gene expressions |
abstract | The invention provides siRNA and its application that a species specificity suppresses CTGF genes.The positive-sense strand and antisense strand sequence of siRNA of the present invention are respectively as shown in SEQ ID NO.1 2.The CTGF target sequences of siRNA interference are as shown in SEQ ID NO.3, it suppresses CTGF gene expressions by acting on CTGF target sequences and realizing, available for the medicine for preparing CTGF gene expressions in regulation cell or organism, it can also be used for preparing the medicine for the treatment of tumour, especially melanoma, have broad application prospects. |
priorityDate | 2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.